Wilson D G, Ahmed N, Nolan R, Frontera A, Thomas G, Duncan E R
University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, SO16 6YD.
Bristol Heart Institute, University Bristol Hospitals NHS Foundation Trust, Malborough street, Bristol BS6 8HW.
Indian Pacing Electrophysiol J. 2015 Apr 1;15(1):4-14. doi: 10.1016/s0972-6292(16)30836-1. eCollection 2015 Jan-Feb.
Limited data exist on outcomes in very elderly ICD recipients. We describe outcomes in new ICD and Cardiac Resynchronisation Therapy with Defibrillator (CRT-D) implants in octogenarians at our institution.
Patients aged 80 years and above who underwent de novo ICD or CRT-D implantation from January 2006 to July 2012 were identified. Clinical data were collected from the procedural record, medical and ICD notes. Baseline characteristics were compared using independent sample t test for continuous variables and Fisher's exact test for categorical variables. Kaplan-Meier curves were constructed.
Ten per cent of all new ICD/CRT-D implants were aged 80 years and over. Median age was 83.0 years. Median follow-up was 29 months. Death occurred in 17 (34%). Median time to death was 23 months. Three deaths (6%) occurred within 12 months of ICD implantation. Appropriate therapy (ATP or shock) occurred in 19 (38%). Inappropriate therapy occurred in 6 (12%). Rates of appropriate shocks and inappropriate therapy (shocks and ATP) and significant valvular incompetence were higher amongst deceased patients (P=0.03 OR 5.9 95% CI 1.3-27) and (P=0.02 OR 12 95% CI 1.3-112). Univariate analysis identified diuretic use (P=0.008 95% C.I. 0.05 to 0.63) and appropriate shock (P= 0.025 95% C.I. 1.25 to 26.3) as predictors of mortality.
Octogenarians make up a small but increasing number of ICD recipients. This study highlights high survival rates at one year with acceptable rates of appropriate and inappropriate device therapy. Ongoing debate regarding the appropriateness of ICD in very elderly patients is warranted.
关于高龄植入式心脏复律除颤器(ICD)接受者的预后数据有限。我们描述了在我们机构中80岁及以上患者接受新的ICD和心脏再同步化治疗除颤器(CRT-D)植入后的预后情况。
确定2006年1月至2012年7月期间接受初次ICD或CRT-D植入的80岁及以上患者。从手术记录、医疗和ICD记录中收集临床数据。连续变量采用独立样本t检验,分类变量采用Fisher精确检验比较基线特征。构建Kaplan-Meier曲线。
所有新的ICD/CRT-D植入患者中,10%的患者年龄在80岁及以上。中位年龄为83.0岁。中位随访时间为29个月。17例(34%)患者死亡。死亡的中位时间为23个月。3例(6%)死亡发生在ICD植入后12个月内。适当治疗(抗心动过速起搏或电击)发生在19例(38%)患者中。不适当治疗发生在6例(12%)患者中。在死亡患者中,适当电击率、不适当治疗(电击和抗心动过速起搏)率以及严重瓣膜功能不全发生率更高(P = 0.03,比值比5.9,95%可信区间1.3 - 27)以及(P = 0.02,比值比12,95%可信区间1.3 - 112)。单因素分析确定使用利尿剂(P = 0.008,95%置信区间0.05至0.63)和适当电击(P = 0.025,95%置信区间1.25至26.3)为死亡率的预测因素。
80岁及以上患者占ICD接受者的比例虽小但在增加。本研究强调了1年时的高生存率以及适当和不适当器械治疗的可接受率。关于ICD在高龄患者中应用的适当性的持续争论是有必要的。